Shopping Cart
- Remove All
Your shopping cart is currently empty
AZD1979 is a highly potent MCHR1 (Melanin-concentrating hormone receptor 1) antagonist with an IC50 of 12 nM, exhibiting improved central nervous system (CNS) exposure and enhanced insulin sensitivity in steady-state model assessments, making it suitable for the treatment of obesity.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $58 | In Stock | |
| 5 mg | $139 | In Stock | |
| 10 mg | $222 | In Stock | |
| 25 mg | $438 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $153 | In Stock |
| Description | AZD1979 is a highly potent MCHR1 (Melanin-concentrating hormone receptor 1) antagonist with an IC50 of 12 nM, exhibiting improved central nervous system (CNS) exposure and enhanced insulin sensitivity in steady-state model assessments, making it suitable for the treatment of obesity. |
| Targets&IC50 | MCH1R:~12 nM |
| In vivo | Method: AZD1979 was administered orally once daily for several days to diet-induced obese (DIO) mice. Body weight, food intake, fasting blood glucose, and insulin levels were monitored to evaluate its effects on energy metabolism. Result: AZD1979 dose-dependently reduced body weight and food intake, and significantly improved fasting glucose and insulin levels, indicating a beneficial role in metabolic regulation. [1] |
| Synonyms | AZD 1979 |
| Molecular Weight | 462.5 |
| Formula | C25H26N4O5 |
| Cas No. | 1254035-84-1 |
| Smiles | O=C(C1=NN=C(O1)C=2C=CC(OC)=CC2)N3CC(OC4=CC=C(C=C4)CN5CC6(COC6)C5)C3 |
| Relative Density. | 1.41 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 30 mg/mL (64.86 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.32 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.